Cardiac involvement of myotonic dystrophy type II in patients with preserved ejection fraction - Detection by CMR
نویسندگان
چکیده
Methods We prospectively enrolled 32 subjects with a genetically confirmed diagnosis of MD2. Exclusion criteria were known cardiac diseases and contraindication for CMR. We assessed left-ventricular (LV) volumes, mass and function applying state of the art cine imaging using a 1.5 T Scanner. Late enhancement imaging (LGE; slice thickness (sth) 7 mm) was performed to detect myocardial fibrosis 10 minutes after injection of gadoteridol (0.2 mmol/kgbw). We applied T1 Mapping based on MOLLI (TI native 211 ms, TI post-contrast 281 ms, TE 1.08 ms, sth 6 mm) before and 15 minutes after contrast application and assessed resultant extracellular volume fraction (ECV). Fat-water-separated imaging (GRE, TR 944.80 ms, TE 1.53-8.22 ms, sth 6 mm) was performed to identify myocardial fat deposits. Furthermore, we used H magnetic resonance spectroscopy (MRS) (TR 1600 ms, TE 35 ms, septal voxel 20 x 15 x 6 mm3) to quantify myocardial Triglycerides (MTG). Data were analyzed using cvi and standard line-fitting procedure. Results 26 data sets were totally completed (age 53.8 ± 11 y, LVEF 65 ± 0.6 %, 19 women). None of the patients had wall motion abnormalities. LGE was detectable in 6 of 28 subjects (LGE+; 3 women); the location was mostly subepicardial inferolateral basal (Figure 1). In case of LGE+, the T1-values of the enhanced regions were significantly different to remote myocardium in both the native (p = 0.03) and the post-contrast maps (p = 0.03). ECV and T1 values of the remote myocardium were not different between LGE+ and LGE negative (LGE-) groups besides to the inferolateral located ECV (25.6 % vs. 34.3 %, p = 0.03) (Figure 2). Fat deposits were noticeable in 6 of 30 subjects (all women, one with LGE +) in the apical portion of the interventricular septum. The content of MTG in LGE+ and LGEsubjects was not significant different (0.34 % vs. 0.74 %, p = 0.47).
منابع مشابه
Cardiac involvement of the systemic disorder myotonic dystrophy type II - detection by CMR
Background Myotonic dystrophy type II (formerly denoted as proximal myotonic myopathy (PROMM)) is an autosomal dominantly inherited disease [1]. Sufferers are afflicted with skeletal muscle (SM) symptoms. Histopathologic changes of the SM include mild fibrosis and fatty degeneration[2]. The multisystemic disorder is also characterized by endocrine and metabolism disorder such as hypercholestero...
متن کاملCardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
BACKGROUND Myotonic dystrophy type 2 (DM2) is a genetic disorder characterized by skeletal muscle symptoms, metabolic changes, and cardiac involvement. Histopathologic alterations of the skeletal muscle include fibrosis and fatty infiltration. The aim of this study was to investigate whether subclinical cardiac involvement in DM2 is already detectable in preserved left ventricular function by c...
متن کاملMyocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study
BACKGROUND Myotonic dystrophy type 1 (DM1) is associated with increased cardiac morbidity and mortality. Therefore, assessment of cardiac involvement and risk stratification for sudden cardiac death is crucial. Nevertheless, optimal screening-procedures are not clearly defined. ECG, echocardiography and Holter-monitoring are useful but insufficient. Cardiovascular magnetic resonance (CMR) can p...
متن کاملStructural myocardial involvement in adult patients with type 1 myotonic dystrophy
Myotonic dystrophy type 1 (DM1) is the commonest muscular dystrophy in adults, affecting multiple organs in addition to skeletal muscles. Cardiac conduction system abnormalities are well recognized as an important component of DM1 phenotype; however, primary structural myocardial abnormalities, which may predispose these patients to congestive heart failure, are not as well characterized. We re...
متن کاملRepeats and Survival in Myotonic Dystrophy Type 1.
The myotonic dystrophies are multisystem disorders characterized by progressive skeletal muscle weakness, myotonia, cataracts, endocrine abnormalities, cognitive impairment, and cardiomyopathy. Myotonic dystrophy type 1 (DM1) is the most common of the myotonic dystrophies. The cardiac-specific phenotypes of DM1 include progressive atrioventricular conduction delay, atrial and ventricular arrhyt...
متن کامل